A client has been diagnosed with vulvovaginitis caused by Trichomonas vaginalis. Which treatments should the nurse anticipate being prescribed for this client? Select all that apply:

Choice A rationale:

Anaerobic bacteria are not responsible for the described symptoms. They typically cause foul-smelling discharge with a different consistency.

Choice B rationale:

Fungi, such as Candida species, commonly cause vaginal candidiasis, which presents with thick, white, cottage cheese-like discharge. This matches the client's symptoms.

Choice C rationale:

Protozoa, like Trichomonas vaginalis, usually lead to a frothy, greenish-yellow discharge with a foul odor, which doesn't align with the client's presentation.

Choice D rationale:

Low estrogen levels would not directly cause this type of discharge. They might lead to vaginal dryness and thinning of vaginal walls, but not the specific discharge described.

Choice E rationale:

Human papillomavirus (HPV) doesn't typically cause the described discharge. It's associated with genital warts and cervical changes but not with this type of discharge.

Choice A rationale:

Administering oral or intravaginal antibiotics is not appropriate for vulvovaginal candidiasis (CV) since it is caused by a fungal infection, not bacterial. Antifungal medications are the primary treatment.

Choice B rationale:

Educating the client on the causes, symptoms, and prevention of CV is essential to ensure the client understands the infection, its symptoms, and how to prevent recurrence.

Choice C rationale:

Providing comfort measures to relieve irritation and discomfort, such as soothing creams and warm sitz baths, helps alleviate the discomfort associated with CV.

Choice D rationale:

Encouraging the client to avoid sexual intercourse during treatment is advised to prevent further irritation and disruption of the vaginal flora.

Choice E rationale:

Advising the client to limit sexual partners is not a specific intervention for CV.